These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7494341)

  • 21. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of 12-o-tetradecanoylphorbol-13-acetate-induced cellular proteins that compete with the Epstein-Barr virus nuclear antigen 1 (EBNA-1) for binding to a site within the Epstein-Barr virus oriP.
    Nonoyama M; Wen LT; Tanaka A; Bradley G
    Adv Exp Med Biol; 1990; 278():125-36. PubMed ID: 1963029
    [No Abstract]   [Full Text] [Related]  

  • 23. Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus.
    Jiang H; Cho YG; Wang F
    J Virol; 2000 Jul; 74(13):5921-32. PubMed ID: 10846073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleoprotein complexes and DNA 5'-ends at oriP of Epstein-Barr virus.
    Niller HH; Glaser G; Knüchel R; Wolf H
    J Biol Chem; 1995 May; 270(21):12864-8. PubMed ID: 7759544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spontaneous loss of viral episomes accompanying Epstein-Barr virus reactivation in a Burkitt's lymphoma cell line.
    Srinivas SK; Sample JT; Sixbey JW
    J Infect Dis; 1998 Jun; 177(6):1705-9. PubMed ID: 9607853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of Epstein-Barr virus nuclear antigen-1 in targeted therapy of EBV-associated neoplasia.
    Judde JG; Spangler G; Magrath I; Bhatia K
    Hum Gene Ther; 1996 Mar; 7(5):647-53. PubMed ID: 8845390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.
    Lear AL; Rowe M; Kurilla MG; Lee S; Henderson S; Kieff E; Rickinson AB
    J Virol; 1992 Dec; 66(12):7461-8. PubMed ID: 1331531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells.
    Sugiura M; Imai S; Tokunaga M; Koizumi S; Uchizawa M; Okamoto K; Osato T
    Br J Cancer; 1996 Aug; 74(4):625-31. PubMed ID: 8761381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon-independent and -induced regulation of Epstein-Barr virus EBNA-1 gene transcription in Burkitt lymphoma.
    Nonkwelo C; Ruf IK; Sample J
    J Virol; 1997 Sep; 71(9):6887-97. PubMed ID: 9261415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Epstein-Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines.
    Schaefer BC; Strominger JL; Speck SH
    J Virol; 1995 Aug; 69(8):5039-47. PubMed ID: 7609074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator.
    Cohen JI; Kieff E
    J Virol; 1991 Nov; 65(11):5880-5. PubMed ID: 1656076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site.
    Sample J; Brooks L; Sample C; Young L; Rowe M; Gregory C; Rickinson A; Kieff E
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6343-7. PubMed ID: 1648738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1.
    Wu DY; Kalpana GV; Goff SP; Schubach WH
    J Virol; 1996 Sep; 70(9):6020-8. PubMed ID: 8709224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection.
    Contreras-Salazar B; Ehlin-Henriksson B; Klein G; Masucci MG
    J Virol; 1990 Nov; 64(11):5441-7. PubMed ID: 2170681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells.
    Schlager S; Speck SH; Woisetschläger M
    J Virol; 1996 Jun; 70(6):3561-70. PubMed ID: 8648690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parallel existence of Epstein-Barr virus (EBV) positive and negative cells in a sporadic case of Burkitt lymphoma.
    Trivedi P; Zhang QJ; Chen F; Minarovits J; Ekman M; Biberfeld P; Klein G; Winberg G
    Oncogene; 1995 Aug; 11(3):505-10. PubMed ID: 7630634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro V(D)J recombination: signal joint formation.
    Cortes P; Weis-Garcia F; Misulovin Z; Nussenzweig A; Lai JS; Li G; Nussenzweig MC; Baltimore D
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14008-13. PubMed ID: 8943051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product.
    Adamson AL; Kenney SC
    Virology; 1998 Nov; 251(1):187-97. PubMed ID: 9813214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying the Cellular Interactome of Epstein-Barr Virus Lytic Regulator Zta Reveals Cellular Targets Contributing to Viral Replication.
    Zhou Y; Heesom K; Osborn K; AlMohammed R; Sweet SM; Sinclair AJ
    J Virol; 2020 Jan; 94(3):. PubMed ID: 31694936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene.
    Zimber-Strobl U; Suentzenich KO; Laux G; Eick D; Cordier M; Calender A; Billaud M; Lenoir GM; Bornkamm GW
    J Virol; 1991 Jan; 65(1):415-23. PubMed ID: 1845900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.